CytRx’s Executive Vice President and Chief Medical Officer Dr. Daniel Levitt to Present Oncology Grand Rounds at LSU Medical School

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, announced that Executive Vice President and Chief Medical Officer Daniel Levitt, M.D., Ph.D., will give the Grand Rounds presentation today to the prestigious Department of Hematology and Oncology at LSU Medical School in New Orleans. The presentation, “The Diversity of Albumin-Linked Cancer Drugs,” will focus on advancements in CytRx’s program with aldox Reported by Business Wire 6 hours ago.